vs

Side-by-side financial comparison of Cellebrite DI Ltd. (CLBT) and Real Brokerage Inc (REAX). Click either name above to swap in a different company.

Real Brokerage Inc is the larger business by last-quarter revenue ($568.5M vs $292.2M, roughly 1.9× Cellebrite DI Ltd.). Real Brokerage Inc runs the higher net margin — -0.1% vs -103.5%, a 103.4% gap on every dollar of revenue. Cellebrite DI Ltd. produced more free cash flow last quarter ($60.8M vs $8.4M).

Cellebrite DI Ltd. is a digital forensics company headquartered in Petah Tikva, Israel that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED.

Anywhere Real Estate Inc., formerly Realogy, was an American real estate services firm. It operated and franchised real estate brands that provided brokerage, relocation, title, insurance, and settlement services. Brands included Better Homes and Gardens Real Estate, Century 21 Real Estate, Coldwell Banker, Corcoran Group, ERA Real Estate and Sotheby's International Realty. In 2026, the company was acquired by Compass, Inc.

CLBT vs REAX — Head-to-Head

Bigger by revenue
REAX
REAX
1.9× larger
REAX
$568.5M
$292.2M
CLBT
Higher net margin
REAX
REAX
103.4% more per $
REAX
-0.1%
-103.5%
CLBT
More free cash flow
CLBT
CLBT
$52.4M more FCF
CLBT
$60.8M
$8.4M
REAX

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
CLBT
CLBT
REAX
REAX
Revenue
$292.2M
$568.5M
Net Profit
$-302.3M
$-447.0K
Gross Margin
84.6%
7.9%
Operating Margin
14.1%
-0.1%
Net Margin
-103.5%
-0.1%
Revenue YoY
52.6%
Net Profit YoY
82.7%
EPS (diluted)
$-1.50
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLBT
CLBT
REAX
REAX
Q3 25
$292.2M
$568.5M
Q2 25
$220.8M
$540.7M
Q1 25
$89.6M
$354.0M
Q3 24
$232.1M
$372.5M
Q2 24
$185.3M
Q1 24
$71.2M
$200.7M
Q3 23
$196.6M
Q2 23
$97.9M
Net Profit
CLBT
CLBT
REAX
REAX
Q3 25
$-302.3M
$-447.0K
Q2 25
$36.9M
$1.5M
Q1 25
$-71.4M
$-5.0M
Q3 24
$-2.6M
Q2 24
$-95.2M
Q1 24
$-40.6M
$-16.1M
Q3 23
$113.7M
Q2 23
$-73.0M
Gross Margin
CLBT
CLBT
REAX
REAX
Q3 25
84.6%
7.9%
Q2 25
84.1%
8.9%
Q1 25
85.2%
9.6%
Q3 24
83.5%
8.6%
Q2 24
84.1%
Q1 24
82.6%
10.3%
Q3 23
80.4%
Q2 23
Operating Margin
CLBT
CLBT
REAX
REAX
Q3 25
14.1%
-0.1%
Q2 25
12.1%
0.3%
Q1 25
10.3%
-1.5%
Q3 24
7.9%
-0.7%
Q2 24
11.7%
Q1 24
0.2%
-7.8%
Q3 23
-4.4%
Q2 23
4.9%
Net Margin
CLBT
CLBT
REAX
REAX
Q3 25
-103.5%
-0.1%
Q2 25
16.7%
0.3%
Q1 25
-79.7%
-1.4%
Q3 24
-0.7%
Q2 24
-51.4%
Q1 24
-57.0%
-8.0%
Q3 23
57.8%
Q2 23
-74.5%
EPS (diluted)
CLBT
CLBT
REAX
REAX
Q3 25
$-1.50
$0.00
Q2 25
$0.15
$0.01
Q1 25
$-0.36
$-0.02
Q3 24
$-0.35
$-0.01
Q2 24
$-0.48
Q1 24
$-0.21
$-0.09
Q3 23
$0.56
Q2 23
$-0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLBT
CLBT
REAX
REAX
Cash + ST InvestmentsLiquidity on hand
$191.7M
$38.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$336.0M
$53.6M
Total Assets
$690.6M
$145.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLBT
CLBT
REAX
REAX
Q3 25
$191.7M
$38.7M
Q2 25
$326.1M
$49.7M
Q1 25
$191.7M
$24.7M
Q3 24
$189.5M
$22.6M
Q2 24
$178.6M
Q1 24
$189.5M
$20.1M
Q3 23
$87.6M
Q2 23
$168.1M
Stockholders' Equity
CLBT
CLBT
REAX
REAX
Q3 25
$336.0M
$53.6M
Q2 25
$408.4M
$49.2M
Q1 25
$336.0M
$32.8M
Q3 24
$34.2M
$29.8M
Q2 24
$-40.2M
Q1 24
$34.2M
$25.6M
Q3 23
$73.9M
Q2 23
$17.6M
Total Assets
CLBT
CLBT
REAX
REAX
Q3 25
$690.6M
$145.2M
Q2 25
$787.4M
$149.4M
Q1 25
$690.6M
$100.5M
Q3 24
$532.9M
$102.5M
Q2 24
$556.6M
Q1 24
$532.9M
Q3 23
$403.3M
Q2 23
$425.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLBT
CLBT
REAX
REAX
Operating Cash FlowLast quarter
$66.2M
$8.8M
Free Cash FlowOCF − Capex
$60.8M
$8.4M
FCF MarginFCF / Revenue
20.8%
1.5%
Capex IntensityCapex / Revenue
1.8%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$172.1M
$71.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLBT
CLBT
REAX
REAX
Q3 25
$66.2M
$8.8M
Q2 25
$53.5M
$41.0M
Q1 25
$10.0M
$15.9M
Q3 24
$58.2M
$7.2M
Q2 24
$24.6M
Q1 24
$12.5M
$21.5M
Q3 23
$-15.2M
Q2 23
$29.1M
Free Cash Flow
CLBT
CLBT
REAX
REAX
Q3 25
$60.8M
$8.4M
Q2 25
$47.5M
$40.8M
Q1 25
$8.5M
$15.7M
Q3 24
$55.3M
$6.8M
Q2 24
$21.0M
Q1 24
$11.4M
$21.4M
Q3 23
$-20.7M
Q2 23
$27.2M
FCF Margin
CLBT
CLBT
REAX
REAX
Q3 25
20.8%
1.5%
Q2 25
21.5%
7.5%
Q1 25
9.5%
4.4%
Q3 24
23.8%
1.8%
Q2 24
11.3%
Q1 24
16.0%
10.7%
Q3 23
-10.5%
Q2 23
27.8%
Capex Intensity
CLBT
CLBT
REAX
REAX
Q3 25
1.8%
0.1%
Q2 25
2.7%
0.0%
Q1 25
1.7%
0.1%
Q3 24
1.3%
0.1%
Q2 24
1.9%
Q1 24
1.5%
0.0%
Q3 23
2.8%
Q2 23
1.9%
Cash Conversion
CLBT
CLBT
REAX
REAX
Q3 25
Q2 25
1.45×
27.13×
Q1 25
Q3 24
Q2 24
Q1 24
Q3 23
-0.13×
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLBT
CLBT

Subscription services$197.2M67%
Term-license$60.8M21%
Professional services$23.2M8%
Other non-recurring$11.0M4%

REAX
REAX

Segment breakdown not available.

Related Comparisons